Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study

作者：Neil D. Gross, David M. Miller, Nikhil I. Khushalani, Vasu Divi, Emily S. Ruiz, Evan J. Lipson, Friedegund Meier, Yungpo Bernard Su, Paul Swiecicki, Jennifer Atlas, J.L. Geiger, Axel Hauschild, Jennifer H. Choe, Brett Hughes, Dirk Schadendorf, Vishal Patel, Jade Homsi, Janis M. Taube, Annette M. Lim, Renata Ferrarotto, Suk‐Young Yoo, Melissa Mathias, Hyunsil Han, Frank Seebach, Israel Lowy, Matthew G. Fury, Danny Rischin · 发表于：The Lancet Oncology · 年份：2023 · DOI：10.1016/s1470-2045(23)00459-x · 被引用次数：108 · 研究领域：Nonmelanoma Skin Cancer Studies、Cutaneous Melanoma Detection and Management、Cancer and Skin Lesions